SAN DIEGO, Dec. 8, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that the Company's CEO Dr. Stuart Titus will be speaking at the Community Alliance Program's First Annual Cannabis 4 the Cause event on Saturday, December 9, 2017 at Montezuma Hall on the San Diego State University campus. He will join other industry experts, including retired professional NFL player Kyle Turley, in a discussion on Chronic Traumatic Encephalopathy (CTE), and cannabinoid research being conducted by the Company and others on treatment of the debilitating disease.
In his presentation, Dr. Titus will discuss how CTE is a condition plaguing NFL players across the nation and outline current research on cannabinoids with respects to CTE.
"We are honored to participate in the first ever public cannabis event being held at San Diego State University," said Medical Marijuana, Inc CEO Dr. Titus. "With an increasing number of cases of CTE being diagnosed this subject is important to discuss and explore."
Dr. Titus and NFL legend Kyle Turley will be available for interview on-site and after the event.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
FORWARD-LOOKING DISCLAIMER AND DISCLOSURES
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.
The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease. The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.
SOURCE Medical Marijuana, Inc.